Business News • PR NewsWire • Hansa Biopharma provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference

Hansa Biopharma provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference

Hansa Biopharma provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference

Commercial launch activities for Idefirix® progressing as planned Patient recruitment in the two phase 2 studies in AMR and GBS was reinitiated in December 2020 Year-end cash position of SEK 1.4 billion LUND, Sweden, Jan. 11, 2021 /PRNewswire/ -- Hansa Biopharma, the leader in...

View More : https://www.prnewswire.com:443/news-releases/hansa-biopharma-provides-business-update-incl-certain-key-financials-ahead-...

Releted News by prnewswire

BioInvent streamlines agreement on anti-FcγRllB antibody, BI-1206, ahead of Phase I/II data

Zoomd startet seine intelligente Self-Serve SaaS-Plattform zur Verwaltung von Werbekampagnen